BusinessTrevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute PainBy Nasdaq OMXJan 4, 2017, 12:01 PM UTC
BusinessTrevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute PainBy Nasdaq OMXJan 4, 2017, 12:01 PM UTC
BusinessAbCellera Completes Antibody Discovery Project With Kodiak Sciences to Identify Lead Therapeutic CandidatesBy Nasdaq OMXAug 24, 2016, 1:00 PM UTC
BusinessGlobal Fragment-based Drug Discovery Market to Reach US$1.2 bn by 2023, Asia Pacific to Witness Highest Growth: Transparency Market ResearchBy Nasdaq OMXApr 15, 2016, 9:30 AM UTC
BusinessCantabio Pharmaceuticals Announces the Development of Small Molecule Chaperones of the Abeta Peptide for the Treatment of Alzheimer's Disease in Collaboration with NovAliXBy Nasdaq OMXApr 12, 2016, 4:00 PM UTC
BusinessTeva and AbCellera Enter Into Agreement to Discover Rare Monoclonal AntibodiesBy Nasdaq OMXFeb 2, 2016, 1:00 PM UTC
